| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $28.5M | -7.4% |
| Cost of Revenue | $15.3M | -49.6% |
| R&D Expense | $11.4M | -54.1% |
| SG&A Expense | $35.1M | -32.2% |
| Operating Income | -$33.3M | +67.9% |
| Pre-tax Income | -$26.3M | +76.5% |
| Income Tax | $67K | +103.0% |
| Net Income | -$26.4M | +76.4% |
| EPS (Basic) | -$4.85 | +94.5% |
| EPS (Diluted) | -$4.85 | +94.5% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $3.0M | -67.4% |
| Accounts Receivable | $5.2M | +9.4% |
| Inventory | $7.8M | -41.0% |
| Current Assets | $45.4M | +14.9% |
| Total Assets | $73.6M | -4.0% |
| Current Liabilities | $22.9M | -38.6% |
| Total Liabilities | $29.2M | -29.4% |
| Stockholders' Equity |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$16.3M | +76.3% |
| Investing Cash Flow | -$12.7M | -117.3% |
| Financing Cash Flow | $24.0M | +275.7% |
| $44.4M |
| +25.6% |